Peripheral arterial disease epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) |
|||
| (18 intermediate revisions by 5 users not shown) | |||
| Line 2: | Line 2: | ||
{{Peripheral arterial disease}} | {{Peripheral arterial disease}} | ||
'''Editors-in-Chief: [[C. Michael Gibson] | '''Editors-in-Chief:''' [[C. Michael Gibson]]; '''Associate Editor-In-Chief:''' {{CZ}}; [[User:Rim Halaby|Rim Halaby]] | ||
==Overview== | ==Overview== | ||
The prevalence of [[peripheral arterial disease]] varies considerably depending on the definition of PAD as well as on the age of the studied population. The overall prevalence of peripheral arterial disease in the general population is 12–14%. The prevalence of PAD is higher in the elderly and affects up to 20% of patients over the age of 70 years. | |||
== Epidemiology and Demographics == | ==Epidemiology and Demographics== | ||
*The overall prevalence of peripheral vascular disease in the general population is 12–14%, affecting up to 20% of those over 70.<ref name="pmid=17580733>{{cite journal |author=Shammas NW |title=Epidemiology, classification, and modifiable risk factors of peripheral arterial disease |journal=[[Vascular Health and Risk Management]] |volume=3 |issue=2 |pages=229–34 |year=2007 |pmid=17580733 |pmc=1994028 |doi= |url=}}</ref><ref name="pmid22572416">{{cite journal| author=Sarangi S, Srikant B, Rao DV, Joshi L, Usha G| title=Correlation between peripheral arterial disease and coronary artery disease using ankle brachial index-a study in Indian population. | journal=Indian Heart J | year= 2012 | volume= 64 | issue= 1 | pages= 2-6 | pmid=22572416 | doi=10.1016/S0019-4832(12)60002-9 | pmc=3860717 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22572416 }} </ref> | |||
* | * The incidence of symptomatic disease increases with age. It starts at about 0.3% per year for men aged 40–55 years and some studies have shown it to rise to about 1% per year for male patients aolder than 75 years.<ref name="3rx">{{cite web | author = | title =Peripheral arterial disease prevention and prevalence | work =Peripheral Arterial Disease | url=http://www.3-rx.com/ab/more/peripheral-arterial-disease-prevention-and-prevalence/ | year = 2007 | month= Nov 1 | publsiher=Your Health Encyclopedia | accessdate=2007-12-03}}</ref><ref name="pmid15287833">{{cite journal| author=Norman PE, Eikelboom JW, Hankey GJ| title=Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. | journal=Med J Aust | year= 2004 | volume= 181 | issue= 3 | pages= 150-4 | pmid=15287833 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15287833 }} </ref> | ||
* 70%–80% of the patients are asymptomatic and very few patients will ever require revascularisation or amputation. | |||
* Peripheral vascular disease affects 1 in 3 diabetics older than 50.<ref name="pmid26185603">{{cite journal| author=Thiruvoipati T, Kielhorn CE, Armstrong EJ| title=Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. | journal=World J Diabetes | year= 2015 | volume= 6 | issue= 7 | pages= 961-9 | pmid=26185603 | doi=10.4239/wjd.v6.i7.961 | pmc=4499529 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26185603 }} </ref> | |||
* Approximately 6.5 million people in America have PVD.<ref name="pmid31992061">{{cite journal| author=Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP | display-authors=etal| title=Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. | journal=Circulation | year= 2020 | volume= 141 | issue= 9 | pages= e139-e596 | pmid=31992061 | doi=10.1161/CIR.0000000000000757 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31992061 }} </ref> Despite its prevalence and cardiovascular risk implications, only 25 percent of PAD patients are undergoing treatment.<ref name="pmid19008688">{{cite journal| author=Gardner AW, Afaq A| title=Management of lower extremity peripheral arterial disease. | journal=J Cardiopulm Rehabil Prev | year= 2008 | volume= 28 | issue= 6 | pages= 349-57 | pmid=19008688 | doi=10.1097/HCR.0b013e31818c3b96 | pmc=2743684 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19008688 }} </ref> | |||
=== | |||
The | |||
==References== | ==References== | ||
Latest revision as of 19:17, 6 October 2020
Editors-in-Chief: C. Michael Gibson; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [1]; Rim Halaby
Overview
The prevalence of peripheral arterial disease varies considerably depending on the definition of PAD as well as on the age of the studied population. The overall prevalence of peripheral arterial disease in the general population is 12–14%. The prevalence of PAD is higher in the elderly and affects up to 20% of patients over the age of 70 years.
Epidemiology and Demographics
- The overall prevalence of peripheral vascular disease in the general population is 12–14%, affecting up to 20% of those over 70.[1][2]
- The incidence of symptomatic disease increases with age. It starts at about 0.3% per year for men aged 40–55 years and some studies have shown it to rise to about 1% per year for male patients aolder than 75 years.[3][4]
- 70%–80% of the patients are asymptomatic and very few patients will ever require revascularisation or amputation.
- Peripheral vascular disease affects 1 in 3 diabetics older than 50.[5]
- Approximately 6.5 million people in America have PVD.[6] Despite its prevalence and cardiovascular risk implications, only 25 percent of PAD patients are undergoing treatment.[7]
References
- ↑ Shammas NW (2007). "Epidemiology, classification, and modifiable risk factors of peripheral arterial disease". Vascular Health and Risk Management. 3 (2): 229–34. PMC 1994028. PMID 17580733.
- ↑ Sarangi S, Srikant B, Rao DV, Joshi L, Usha G (2012). "Correlation between peripheral arterial disease and coronary artery disease using ankle brachial index-a study in Indian population". Indian Heart J. 64 (1): 2–6. doi:10.1016/S0019-4832(12)60002-9. PMC 3860717. PMID 22572416.
- ↑ "Peripheral arterial disease prevention and prevalence". Peripheral Arterial Disease. 2007. Retrieved 2007-12-03. Unknown parameter
|publsiher=ignored (|publisher=suggested) (help); Unknown parameter|month=ignored (help) - ↑ Norman PE, Eikelboom JW, Hankey GJ (2004). "Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications". Med J Aust. 181 (3): 150–4. PMID 15287833.
- ↑ Thiruvoipati T, Kielhorn CE, Armstrong EJ (2015). "Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes". World J Diabetes. 6 (7): 961–9. doi:10.4239/wjd.v6.i7.961. PMC 4499529. PMID 26185603.
- ↑ Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP; et al. (2020). "Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association". Circulation. 141 (9): e139–e596. doi:10.1161/CIR.0000000000000757. PMID 31992061.
- ↑ Gardner AW, Afaq A (2008). "Management of lower extremity peripheral arterial disease". J Cardiopulm Rehabil Prev. 28 (6): 349–57. doi:10.1097/HCR.0b013e31818c3b96. PMC 2743684. PMID 19008688.